CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Decitabine

地西他滨 杂质对照品Decitabine Impurities

USP45 个杂质条目45 impurity entries

本页汇总 地西他滨 的 45 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 45 impurity reference standards of Decitabine with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 地西他滨(Decitabine)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesDevelopment and validation of a liquid chromatography-tandem mass spectrometry method for quantification of decitabine in rat plasma
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2012 · Xu H et al.  ·  PMID 22626892  ·  DOI
  2. 杂质研究Impurity studiesSimultaneous determination of decitabine and vorinostat (Suberoylanalide hydroxamic acid, SAHA) by liquid chromatography tandem mass spectrometry for clinical studies
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2008 · Patel K et al.  ·  PMID 18221921  ·  DOI
  3. 杂质研究Impurity studiesQuantitative determination of decitabine incorporation into DNA and its effect on mutation rates in human cancer cells
    Nucleic acids research · 2014 · Öz S et al.  ·  PMID 25159616  ·  DOI
  4. 分析方法Analytical MethodsA novel stability-indicating analytical method development for simultaneous determination of carboplatin and decitabine from nanoparticles
    Journal of separation science · 2020 · Esim O et al.  ·  PMID 32644279  ·  DOI
  5. 分析方法Analytical MethodsDevelopment, validation, and clinical application of a high-performance liquid chromatography-tandem mass spectrometry assay for the quantification of total intracellular β-decitabine nucleotides and genomic DNA incorporated β-decitabine and 5-methyl-2'-deoxycytidine
    Journal of pharmaceutical and biomedical analysis · 2019 · Roosendaal J et al.  ·  PMID 30366147  ·  DOI

地西他滨 —— 原料药与杂质对照品Decitabine — drug substance & impurities

共 46 个条目(含原料药本体)46 items incl. the drug substance
Decitabine structure
USP原料药 APIAPI
地西他滨Decitabine
Decitabine
CAS No.2353-33-5
Chemical FormulaC8H12N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 1 (Decitabine USP Related Compound A) structure
USPA
地西他滨杂质1 (地西他滨USP相关化合物A)Decitabine Impurity 1 (Decitabine USP Related Compound A)
Decitabine Impurity 1 (Decitabine USP Related Compound A)
CAS No.1207459-15-1
Chemical FormulaC21H18Cl2O7
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 2 (Decitabine USP Related Compound B) structure
USPB
地西他滨杂质2 (地西他滨USP相关化合物B)Decitabine Impurity 2 (Decitabine USP Related Compound B)
Decitabine Impurity 2 (Decitabine USP Related Compound B)
CAS No.1034301-08-0
Chemical FormulaC22H18Cl2N4O6
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 3 (Decitabine USP Related Compound C) structure
USPC
地西他滨杂质3 (地西他滨USP相关化合物C)Decitabine Impurity 3 (Decitabine USP Related Compound C)
Decitabine Impurity 3 (Decitabine USP Related Compound C)
CAS No.1140891-02-6
Chemical FormulaC22H18Cl2N4O6
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 4(Alpha-Isomer) structure
4
地西他滨杂质4(Alpha-异构体)Decitabine Impurity 4(Alpha-Isomer)
Decitabine Impurity 4(Alpha-Isomer)
CAS No.22432-95-7
Chemical FormulaC8H12N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 5 structure
5
地西他滨杂质5Decitabine Impurity 5
Decitabine Impurity 5
CAS No.183016-21-9
Chemical FormulaC16H18N4O5
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 9 structure
9
地西他滨杂质9Decitabine Impurity 9
Decitabine Impurity 9
CAS No.21740-23-8
Chemical FormulaC19H15Cl3O5
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 10 structure
10
地西他滨杂质10Decitabine Impurity 10
Decitabine Impurity 10
CAS No.1126-46-1
Chemical FormulaC8H7ClO2
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 11 structure
11
地西他滨杂质11Decitabine Impurity 11
Decitabine Impurity 11
CAS No.69304-64-9
Chemical FormulaC8H14N4O5
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 12 structure
12
地西他滨杂质12Decitabine Impurity 12
Decitabine Impurity 12
CAS No.127999-92-2
Chemical FormulaC6H12O4
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 13 structure
13
地西他滨杂质13Decitabine Impurity 13
Decitabine Impurity 13
CAS No.17676-20-9
Chemical FormulaC6H12O4
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 14 structure
14
地西他滨杂质14Decitabine Impurity 14
Decitabine Impurity 14
CAS No.6160-56-1
Chemical FormulaC6H12O4
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 15 structure
15
地西他滨杂质15Decitabine Impurity 15
Decitabine Impurity 15
CAS No.16832-21-6
Chemical FormulaC12H20O6
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 16 structure
16
地西他滨杂质16Decitabine Impurity 16
Decitabine Impurity 16
CAS No.570410-68-3
Chemical FormulaC7H14N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 17 structure
17
地西他滨杂质17Decitabine Impurity 17
Decitabine Impurity 17
CAS No.178671-74-4
Chemical FormulaC7H14N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 18 structure
18
地西他滨杂质18Decitabine Impurity 18
Decitabine Impurity 18
CAS No.570410-70-7
Chemical FormulaC7H14N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 19 structure
19
地西他滨杂质19Decitabine Impurity 19
Decitabine Impurity 19
CAS No.69304-65-0
Chemical FormulaC7H14N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 20 structure
20
地西他滨杂质20Decitabine Impurity 20
Decitabine Impurity 20
CAS No.933-40-4
Chemical FormulaC8H16O2
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 21 structure
21
地西他滨杂质21Decitabine Impurity 21
Decitabine Impurity 21
CAS No.54199-94-9
Chemical FormulaC4H7N3O
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 25 structure
25
地西他滨杂质25Decitabine Impurity 25
Decitabine Impurity 25
CAS No.10302-79-1
Chemical FormulaC24H24N4O6
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 26 structure
26
地西他滨杂质26Decitabine Impurity 26
Decitabine Impurity 26
CAS No.570410-72-9
Chemical FormulaC7H14N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 28 structure
28
地西他滨杂质28Decitabine Impurity 28
Decitabine Impurity 28
CAS No.127999-91-1
Chemical FormulaC6H12O4
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 29 structure
29
地西他滨杂质29Decitabine Impurity 29
Decitabine Impurity 29
CAS No.2089576-46-3
Chemical FormulaC6H12O4
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 30 structure
30
地西他滨杂质30Decitabine Impurity 30
Decitabine Impurity 30
CAS No.96761-00-1
Chemical FormulaC5H8O3
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 31 structure
31
地西他滨杂质31Decitabine Impurity 31
Decitabine Impurity 31
CAS No.1442660-65-2
Chemical FormulaC15H15ClN4O5
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 33 structure
33
地西他滨杂质33Decitabine Impurity 33
Decitabine Impurity 33
CAS No.896451-03-9
Chemical FormulaC21H20Cl2O6
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 34 structure
34
地西他滨杂质34Decitabine Impurity 34
Decitabine Impurity 34
CAS No.896451-02-8
Chemical FormulaC21H20Cl2O6
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 36 structure
36
地西他滨杂质36Decitabine Impurity 36
Decitabine Impurity 36
CAS No.99886-53-0
Chemical FormulaC20H18Cl2O6
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 37 structure
37
地西他滨杂质37Decitabine Impurity 37
Decitabine Impurity 37
CAS No.57793-81-4
Chemical FormulaC19H15Cl3O5
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 38 structure
38
地西他滨杂质38Decitabine Impurity 38
Decitabine Impurity 38
CAS No.3601-90-9
Chemical FormulaC19H15Cl3O5
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 39 structure
39
地西他滨杂质39Decitabine Impurity 39
Decitabine Impurity 39
CAS No.1241800-48-5
Chemical FormulaC20H18Cl2O6
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 40 structure
40
地西他滨杂质40Decitabine Impurity 40
Decitabine Impurity 40
CAS No.1193165-26-2
Chemical FormulaC22H18Cl2N4O6
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 41 structure
41
地西他滨杂质41Decitabine Impurity 41
Decitabine Impurity 41
CAS No.1254186-98-5
Chemical FormulaC10H14N4O5
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 43 structure
43
地西他滨杂质43Decitabine Impurity 43
Decitabine Impurity 43
CAS No.22432-93-5
Chemical FormulaC12H16N4O6
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 44 structure
44
地西他滨杂质44Decitabine Impurity 44
Decitabine Impurity 44
CAS No.25501-08-0
Chemical FormulaC8H11N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 53 structure
53
地西他滨杂质53Decitabine Impurity 53
Decitabine Impurity 53
CAS No.23397-76-4
Chemical FormulaC18H28O6
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 56 structure
56
地西他滨杂质56Decitabine Impurity 56
Decitabine Impurity 56
CAS No.58109-18-5
Chemical FormulaC19H30O8S
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 63 structure
63
地西他滨杂质63Decitabine Impurity 63
Decitabine Impurity 63
CAS No.2905-65-9
Chemical FormulaC8H7ClO2
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 65 structure
65
地西他滨杂质65Decitabine Impurity 65
Decitabine Impurity 65
CAS No.121213-25-0
Chemical FormulaC5H8O2
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 66 structure
66
地西他滨杂质66Decitabine Impurity 66
Decitabine Impurity 66
CAS No.13436-43-6
Chemical FormulaC5H8O2
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 67 structure
67
地西他滨杂质67Decitabine Impurity 67
Decitabine Impurity 67
CAS No.1442660-66-3
Chemical FormulaC15H15ClN4O5
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 68 structure
68
地西他滨杂质68Decitabine Impurity 68
Decitabine Impurity 68
CAS No.91784-10-0
Chemical FormulaC7H14O4
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 69 structure
69
地西他滨杂质69Decitabine Impurity 69
Decitabine Impurity 69
CAS No.937-22-4
Chemical FormulaC7H5ClO3
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 70 structure
70
地西他滨杂质70Decitabine Impurity 70
Decitabine Impurity 70
CAS No.610-96-8
Chemical FormulaC8H7ClO2
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 72 structure
72
地西他滨杂质72Decitabine Impurity 72
Decitabine Impurity 72
CAS No.7335-25-3
Chemical FormulaC9H9ClO2
Purity>95%询价On request
10mg25mg50mg100mg
Decitabine Impurity 75 structure
75
地西他滨杂质75Decitabine Impurity 75
Decitabine Impurity 75
CAS No.78185-65-6
Chemical FormulaC22H24O6
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

地西他滨 —— 研究文献与合成路线Decitabine — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 地西他滨 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Decitabine. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Novel Insights into the Molecular Mechanism of Action of DNA Hypomethylating Agents: Role of Protein Kinase C δ in Decitabine-Induced Degradation of DNA Methyltransferase 1
    Datta J, Ghoshal K, Motiwala T, et al. · Genes & cancer · 2012 · 被引 15cited 15
  2. Decitabine promotes degradation of DNMT1 and EZH2 via the ubiquitination pathway and inhibits colorectal cancer progression
    Peng XM, Shi XP, Chen H, et al. · Cellular oncology (Dordrecht, Netherlands) · 2025 · 被引 4cited 4

合成与制备工艺专利Synthesis & process patents

  1. PREPARATION OF DECITABINE
    KOLLA NAVEEN KUMAR, NEELAM UDAY KUMAR, BADDAM SUDHAKAR REDDY, GANGULA SRINIVAS · 公开号 US2012046457US2012046457 · 2012
  2. Process for the synthesis of azacitidine and decitabine
    DE FERRA LORENZO, ZENONI MAURIZIO, TURCHETTA STEFANO, ANIBALDI MAURO, et al. · 公开号 EP2371825EP2371825 · 2011
  3. PROCESS FOR THE SYNTHESIS OF AZACITIDINE AND DECITABINE
    DE FERRA LORENZO, ZENONI MAURIZIO, TURCHETTA STEFANO, ANIBALDI MAURO, et al. · 公开号 US2011245485US2011245485 · 2011
  4. PREPARATION OF DECITABINE
    KOLLA NAVEEN KUMAR, NEELAM UDAY KUMAR, BADDAM SUDHAKAR REDDY, GANGULA SRINIVAS · 公开号 EP2424845EP2424845 · 2012
  5. PREPARATION OF DECITABINE
    KOLLA NAVEEN KUMAR, NEELAM UDAY KUMAR, BADDAM SUDHAKAR REDDY, GANGULA SRINIVAS · 公开号 WO2010129211WO2010129211 · 2010

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

地西他滨 杂质谱研究要点Decitabine — impurity profiling notes

下面这些是拿到 地西他滨 的 46 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 46 impurity entries for Decitabine, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances